How can I enroll in the Lapatinib EAP?
Begin by talking to your oncologist about eligibility for the Lapatinib EAP. The call center number for information about the Lapatinib EAP for Canada is 1-888-489-5372. Patients should press (1) and will be transferred to a call center representative at the National Organization for Rare Disorders (NORD). Information on lapatinib studies is available at www.clinicaltrials.gov. Outside the US and Canada, inquiries from physicians can be directed to the following email address: breastcancereap@gsk.com. Patients should consult their physicians.
